Nokia Oyj
15.10.2026 16:00:00 CEST | Globenewswire | Press release
Nokia Corporation - Managers' transactions (Mahajan)
Nokia Corporation - Managers' transactions (Mahajan)
Nokia Corporation
Managers’ transactions
15 October 2026 at 17:00 EEST
Nokia Corporation - Managers' transactions (Mahajan)
Transaction notification under Article 19 of EU Market Abuse Regulation.
____________________________________________
Person subject to the notification requirement
Name: Mahajan, Pallavi
Position: Other senior manager
Issuer: Nokia Corporation
LEI: 549300A0JPRWG1KI7U06
Notification type: INITIAL NOTIFICATION
Reference number: 176599/4/4
___________________________________________
Transaction date: 2026-10-15
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009000681
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 35192 Unit price: N/A
Aggregated transactions
(1): Volume: 35192 Volume weighted average price: N/A
____________________________________________
About Nokia
Nokia is a global leader in connectivity infrastructure, enabling the AI supercycle. We build networks that connect intelligence and deliver a comprehensive connectivity solution across fixed, mobile, IP, optical, core, and data center networks. With security by design, AI-driven innovation, and AI-optimized architecture, Nokia delivers trusted infrastructure that enables AI to scale and advances connectivity to secure a brighter world.
Inquiries:
Nokia Communications
Phone: +358 10 448 4900
Email: press.services@nokia.com
Maria Vaismaa, Vice President, Corporate Communications
Nokia
Investor Relations
Phone: +358 931 580 507
Email: investor.relations@nokia.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Aktieselskabet Schouw & Co.9.11.2026 15:57:33 CET | Press release
Schouw & Co. to initiate share buy-back programme of up to DKK 75 million
Aktieselskabet Schouw & Co.9.11.2026 15:57:33 CET | Pressemeddelelse
Schouw & Co. iværksætter aktietilbagekøbsprogram på op til 75 mio. kr.
Pharma Equity Group A/S9.11.2026 15:51:48 CET | Pressemeddelelse
Bestyrelsens beslutning om udstedelse af konvertible lån
Pharma Equity Group A/S9.11.2026 15:51:48 CET | Press release
The Board of Directors' resolution on the issuance of convertible loans
Zealand Pharma9.11.2026 15:45:00 CET | Press release
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom